| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 738.20M | 977.10M | 963.50M | 848.40M | 658.70M |
| Gross Profit | 169.00M | 173.70M | 174.00M | 148.00M | 101.50M |
| EBITDA | 78.70M | 99.00M | 94.00M | 82.40M | 79.80M |
| Net Income | 29.40M | 25.90M | 31.10M | 20.20M | 24.20M |
Balance Sheet | |||||
| Total Assets | 781.50M | 1.02B | 985.30M | 976.90M | 827.80M |
| Cash, Cash Equivalents and Short-Term Investments | 82.00M | 45.50M | 47.60M | 43.20M | 51.10M |
| Total Debt | 199.30M | 275.10M | 251.40M | 222.10M | 204.20M |
| Total Liabilities | 401.20M | 545.90M | 528.20M | 527.50M | 402.70M |
| Stockholders Equity | 380.30M | 469.90M | 457.10M | 449.40M | 425.10M |
Cash Flow | |||||
| Free Cash Flow | 32.40M | 6.20M | 7.70M | 27.90M | 5.80M |
| Operating Cash Flow | 64.40M | 49.40M | 41.40M | 58.40M | 27.10M |
| Investing Cash Flow | -45.30M | -44.20M | -54.80M | -54.60M | 30.60M |
| Financing Cash Flow | -62.70M | -4.80M | 17.60M | -14.40M | -29.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £67.11B | 24.91 | 17.90% | 1.99% | 11.60% | 8.03% | |
69 Neutral | £99.83B | 16.57 | 227.54% | 0.91% | 9.62% | 146.74% | |
65 Neutral | £1.20B | 27.39 | 7.31% | 1.06% | -13.81% | 13.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.50B | 32.18 | 13.12% | 1.64% | -2.53% | 22.25% | |
58 Neutral | £2.51B | 20.00 | -35.50% | 2.00% | -4.59% | -256.51% | |
41 Neutral | £29.56M | ― | 192.83% | ― | ― | ― |